AAPG
Ascentage Pharma Group International
NASDAQ: AAPG · HEALTHCARE · BIOTECHNOLOGY
$22.48
-2.26% today
Updated 2026-04-29
Market cap
$2.15B
P/E ratio
—
P/S ratio
3.74x
EPS (TTM)
$-2.04
Dividend yield
—
52W range
$19 – $48
Volume
0.0M
Ascentage Pharma Group International (AAPG) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.67M | $6.33M | $6.81M | $14.51M | $12.45M | $27.91M | $209.71M | $221.98M | $980.65M | $558.48M |
| Revenue growth (YoY) | — | -17.5% | +7.6% | +113.2% | -14.2% | +124.2% | +651.4% | +5.9% | +341.8% | -43.1% |
| Cost of revenue | $261000.00 | — | — | $2.10M | $1.97M | $3.33M | $22.00M | $30.54M | $29.09M | $131.73M |
| Gross profit | $7.41M | $6.33M | $6.81M | $12.42M | $10.48M | $24.58M | $187.71M | $191.44M | $951.57M | $426.75M |
| Gross margin | 96.6% | 100.0% | 100.0% | 85.6% | 84.2% | 88.1% | 89.5% | 86.2% | 97.0% | 76.4% |
| R&D | $102.69M | $118.81M | $249.56M | $463.88M | $564.57M | $766.49M | $743.10M | $706.97M | $947.25M | $1.08B |
| SG&A | $17.71M | $13.40M | $89.22M | $98.85M | $62.69M | $143.51M | $170.59M | $181.08M | $187.13M | — |
| Operating income | $-114.62M | $-130.67M | $-50.25M | $-582.68M | $-663.94M | $-869.84M | $-849.81M | $-872.64M | $-369.73M | $-1.18B |
| Operating margin | -1495.0% | -2064.9% | -738.1% | -4014.9% | -5332.9% | -3116.6% | -405.2% | -393.1% | -37.7% | -211.1% |
| EBITDA | $-103.03M | $-49.68M | $-291.53M | $-1.47B | $-652.23M | $-798.34M | $-786.97M | $-743.61M | $-237.63M | $-1.10B |
| EBITDA margin | -1343.9% | -785.0% | -4282.8% | -10157.9% | -5238.8% | -2860.4% | -375.3% | -335.0% | -24.2% | -196.1% |
| EBIT | $-103.20M | $-62.18M | $-309.99M | $-1.48B | $-669.19M | $-815.52M | $-834.39M | $-836.80M | $-330.80M | $-1.18B |
| Interest expense | $3.26M | $57.94M | $36.92M | $4.27M | $6.25M | $16.73M | $52.78M | $96.06M | $64.45M | $52.60M |
| Income tax | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-107.84M | $-118.51M | $-345.31M | $-1.48B | $-677.61M | $-782.42M | $-882.92M | $-925.64M | $-405.43M | $-1.21B |
| Net income growth (YoY) | — | -9.9% | -191.4% | -328.8% | +54.2% | -15.5% | -12.8% | -4.8% | +56.2% | -198.2% |
| Profit margin | -1406.5% | -1872.9% | -5072.8% | -10202.7% | -5442.6% | -2803.4% | -421.0% | -417.0% | -41.3% | -216.5% |